53.02 USD
↗ 0.01 (0.02%)LIVE (AS OF 07:42 PM EDT)
Soleno Therapeutics, Inc. Common Stock
SLNONASDAQ • USD
Market: OPEN
Open?$52.99
High?$53.01
Low?$52.98
Prev. Close?$53.01
Volume?1.6M
Avg. Volume?5.3M
VWAP?$52.99
Rel. Volume?0.30x
Bid / Ask
Bid?$52.99 × 900
Ask?$53.03 × 1.0K
Spread?$0.04
Midpoint?$53.01
Valuation & Ratios
Market Cap?2.8B
Shares Out?52.1M
Float?50.2M
Float %?96.5%
P/E Ratio?28.89
P/B Ratio?5.57
EPS?$1.83
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue. The company's reporting segment focused on the development and commercialization of its sole therapeutic product, VYKAT XR.
Address
100 MARINE PARKWAY, SUITE 400
REDWOOD CITY, CA 94065
Phone: 650-213-8444
REDWOOD CITY, CA 94065
Phone: 650-213-8444
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?5.62Strong
Quick Ratio?5.32Strong
Cash Ratio?2.29Strong
Debt/Equity?0.10Low
ValuationRICHLY VALUED
Score50/100
P/E?28.9FAIR▾
P/B?5.57FAIR▾
P/S?9.69HIGH▾
P/FCF?26.2FAIR▾
EV/EBITDA?29.3HIGH▾
EV/Sales?9.40HIGH▾
Returns & Efficiency
ROE?19.3%STRONG▾
ROA?15.7%STRONG▾
Cash Flow & Enterprise
FCF?$105.4M
Enterprise Value?$2.7B
Fundamentals ratios updated end of day